VRTX logo

VRTX Return On Equity

Annual ROE:

-3.15%-26.14%(-113.70%)
December 31, 2024

Summary

  • As of today, VRTX annual return on equity is -3.15%, with the most recent change of -26.14% (-113.70%) on December 31, 2024.
  • During the last 3 years, VRTX annual ROE has fallen by -28.08% (-112.64%).
  • VRTX annual ROE is now -104.89% below its all-time high of 64.43%, reached on December 31, 2018.

Performance

VRTX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXprofitability metrics

Quarterly ROE:

22.13%-0.47%(-2.08%)
September 30, 2025

Summary

  • As of today, VRTX quarterly return on equity is 22.13%, with the most recent change of -0.47% (-2.08%) on September 30, 2025.
  • Over the past year, VRTX quarterly ROE has increased by +25.02% (+865.74%).
  • VRTX quarterly ROE is now -69.12% below its all-time high of 71.67%, reached on December 31, 2018.

Performance

VRTX Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

VRTX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-113.7%+865.7%
3Y3 Years-112.6%-25.0%
5Y5 Years-114.1%-45.0%

VRTX ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-111.4%at low-25.0%+466.4%
5Y5-Year-108.6%at low-45.0%+466.4%
All-TimeAll-Time-104.9%+98.3%-69.1%+107.6%

VRTX ROE History

DateAnnualQuarterly
Sep 2025
-
22.13%(-2.1%)
Jun 2025
-
22.60%(+474.2%)
Mar 2025
-
-6.04%(-87.0%)
Dec 2024
-3.15%(-113.7%)
-3.23%(-11.8%)
Sep 2024
-
-2.89%(+2.4%)
Jun 2024
-
-2.96%(-112.2%)
Mar 2024
-
24.35%(+4.8%)
Dec 2023
22.99%(-16.9%)
23.23%(-1.8%)
Sep 2023
-
23.65%(-3.3%)
Jun 2023
-
24.46%(-3.6%)
Mar 2023
-
25.38%(-8.5%)
Dec 2022
27.67%(+11.0%)
27.74%(-5.9%)
Sep 2022
-
29.49%(-4.6%)
Jun 2022
-
30.92%(+22.9%)
Mar 2022
-
25.16%(-0.1%)
Dec 2021
24.93%(-32.1%)
25.19%(+3.1%)
Sep 2021
-
24.44%(+4.4%)
Jun 2021
-
23.42%(-32.5%)
Mar 2021
-
34.72%(-5.5%)
Dec 2020
36.71%(+64.1%)
36.76%(-8.6%)
Sep 2020
-
40.22%(+17.5%)
Jun 2020
-
34.24%(+25.1%)
Mar 2020
-
27.38%(+19.0%)
Dec 2019
22.37%(-65.3%)
23.01%(-51.3%)
Sep 2019
-
47.25%(-14.2%)
Jun 2019
-
55.07%(-10.8%)
Mar 2019
-
61.72%(-13.9%)
Dec 2018
64.43%(+1093.1%)
71.67%(+157.4%)
Sep 2018
-
27.84%(+147.5%)
Jun 2018
-
11.25%(+219.6%)
Mar 2018
-
3.52%(-32.6%)
Dec 2017
5.40%(+178.1%)
5.22%(+392.5%)
Sep 2017
-
1.06%(-94.3%)
Jun 2017
-
18.48%(+19.7%)
Mar 2017
-
15.44%(+317.8%)
Dec 2016
-6.91%(+87.1%)
-7.09%(+57.3%)
Sep 2016
-
-16.62%(+24.6%)
Jun 2016
-
-22.03%(+45.0%)
Mar 2016
-
-40.07%(+27.8%)
Dec 2015
-53.72%(+11.2%)
-55.53%(+14.0%)
Sep 2015
-
-64.58%(+8.3%)
Jun 2015
-
-70.41%(-12.3%)
Mar 2015
-
-62.69%(-1.5%)
Dec 2014
-60.49%(-14.0%)
-61.75%(-5.9%)
Sep 2014
-
-58.29%(-12.4%)
Jun 2014
-
-51.88%(-12.7%)
Mar 2014
-
-46.02%(+11.6%)
Dec 2013
-53.08%(-1041.5%)
-52.06%(-16.7%)
Sep 2013
-
-44.62%(-16.8%)
Jun 2013
-
-38.20%(+1.5%)
Mar 2013
-
-38.77%(-765.4%)
Dec 2012
-4.65%(-183.6%)
-4.48%(-122.2%)
Sep 2012
-
20.14%(-61.2%)
Jun 2012
-
51.91%(+25.3%)
Mar 2012
-
41.43%(+550.4%)
Dec 2011
5.56%(+105.9%)
6.37%(+110.5%)
Sep 2011
-
-60.44%(+55.4%)
Jun 2011
-
-135.50%(-19.1%)
Mar 2011
-
-113.79%(-22.7%)
Dec 2010
-94.31%(+2.0%)
-92.75%(-5.6%)
Sep 2010
-
-87.81%(-10.9%)
Jun 2010
-
-79.20%(-1.5%)
Mar 2010
-
-78.03%(+17.9%)
Dec 2009
-96.19%(+46.6%)
-95.00%(+20.1%)
Sep 2009
-
-118.83%(+11.2%)
Jun 2009
-
-133.87%(+6.4%)
Mar 2009
-
-143.05%(+12.6%)
Dec 2008
-180.27%
-163.74%(-21.6%)
Sep 2008
-
-134.66%(-10.6%)
Jun 2008
-
-121.71%(-9.1%)
DateAnnualQuarterly
Mar 2008
-
-111.52%(-15.4%)
Dec 2007
-100.69%(-80.4%)
-96.61%(-31.3%)
Sep 2007
-
-73.59%(-11.6%)
Jun 2007
-
-65.96%(-6.8%)
Mar 2007
-
-61.76%(+1.3%)
Dec 2006
-55.81%(+62.3%)
-62.60%(+26.3%)
Sep 2006
-
-84.90%(+37.8%)
Jun 2006
-
-136.44%(+6.4%)
Mar 2006
-
-145.74%(+25.1%)
Dec 2005
-148.15%(-1.7%)
-194.70%(+33.1%)
Sep 2005
-
-290.95%(-16.4%)
Jun 2005
-
-249.98%(-8.1%)
Mar 2005
-
-231.28%(-58.6%)
Dec 2004
-145.65%(-56.2%)
-145.83%(-36.3%)
Sep 2004
-
-106.96%(-1.7%)
Jun 2004
-
-105.21%(-6.0%)
Mar 2004
-
-99.28%(-53.6%)
Dec 2003
-93.25%(-266.5%)
-64.65%(-19.2%)
Sep 2003
-
-54.23%(-55.8%)
Jun 2003
-
-34.80%(-118.9%)
Mar 2003
-
-15.90%(+37.1%)
Dec 2002
-25.44%(-60.3%)
-25.27%(-26.0%)
Sep 2002
-
-20.06%(-3.7%)
Jun 2002
-
-19.35%(-9.3%)
Mar 2002
-
-17.71%(-17.1%)
Dec 2001
-15.87%(-29.7%)
-15.12%(-7.6%)
Sep 2001
-
-14.05%(+5.6%)
Jun 2001
-
-14.88%(-83.3%)
Mar 2001
-
-8.12%(+33.5%)
Dec 2000
-12.24%(+32.0%)
-12.21%(+2.2%)
Sep 2000
-
-12.48%(-64.4%)
Jun 2000
-
-7.59%(+59.1%)
Mar 2000
-
-18.57%(-0.7%)
Dec 1999
-17.99%(-42.0%)
-18.45%(+22.6%)
Sep 1999
-
-23.83%(-33.6%)
Jun 1999
-
-17.84%(-6.7%)
Mar 1999
-
-16.72%(-30.5%)
Dec 1998
-12.67%(-29.9%)
-12.81%(-26.2%)
Sep 1998
-
-10.15%(+9.9%)
Jun 1998
-
-11.27%(-39.0%)
Mar 1998
-
-8.11%(-1.9%)
Dec 1997
-9.75%(+73.7%)
-7.96%(-3.6%)
Sep 1997
-
-7.68%(+21.6%)
Jun 1997
-
-9.80%(+65.2%)
Mar 1997
-
-28.17%(+31.0%)
Dec 1996
-37.02%(-64.0%)
-40.82%(+1.6%)
Sep 1996
-
-41.49%(+10.7%)
Jun 1996
-
-46.48%(-70.0%)
Mar 1996
-
-27.34%(-20.0%)
Dec 1995
-22.57%(+0.6%)
-22.78%(+14.4%)
Sep 1995
-
-26.61%(-16.5%)
Jun 1995
-
-22.84%(-21.4%)
Mar 1995
-
-18.82%(+2.5%)
Dec 1994
-22.70%(-620.6%)
-19.30%(-284.5%)
Sep 1994
-
-5.02%(-25.2%)
Jun 1994
-
-4.01%(-211.7%)
Mar 1994
-
3.59%(-17.7%)
Dec 1993
4.36%(+124.7%)
4.36%(+119.7%)
Sep 1993
-
-22.11%(-9.5%)
Jun 1993
-
-20.20%(+7.9%)
Mar 1993
-
-21.94%(-26.3%)
Dec 1992
-17.67%(+0.6%)
-17.37%(-12.0%)
Sep 1992
-
-15.51%(+6.0%)
Jun 1992
-
-16.50%(+17.0%)
Mar 1992
-
-19.87%(+14.5%)
Dec 1991
-17.77%(+78.5%)
-23.23%(+43.7%)
Sep 1991
-
-41.29%(+66.5%)
Jun 1991
-
-123.08%(-42.2%)
Mar 1991
-
-86.54%(-4.7%)
Dec 1990
-82.69%
-82.69%

FAQ

  • What is Vertex Pharmaceuticals Incorporated annual return on equity?
  • What is the all-time high annual ROE for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated annual ROE year-on-year change?
  • What is Vertex Pharmaceuticals Incorporated quarterly return on equity?
  • What is the all-time high quarterly ROE for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated quarterly ROE year-on-year change?

What is Vertex Pharmaceuticals Incorporated annual return on equity?

The current annual ROE of VRTX is -3.15%

What is the all-time high annual ROE for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high annual return on equity is 64.43%

What is Vertex Pharmaceuticals Incorporated annual ROE year-on-year change?

Over the past year, VRTX annual return on equity has changed by -26.14% (-113.70%)

What is Vertex Pharmaceuticals Incorporated quarterly return on equity?

The current quarterly ROE of VRTX is 22.13%

What is the all-time high quarterly ROE for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high quarterly return on equity is 71.67%

What is Vertex Pharmaceuticals Incorporated quarterly ROE year-on-year change?

Over the past year, VRTX quarterly return on equity has changed by +25.02% (+865.74%)
On this page